Molecular biology and genetics of Alzheimer's disease (original) (raw)

[1] I.G. McKeith; D.J. Burn; C.G. Ballard; D. Collerton; E. Jaros; C.M. Morris; A. McLaren; E.K. Perry; R. Perry; M.A. Piggott; J.T. O'Brien Dementia with Lewy bodies, Semin. Clin. Neuropsychiatry, Volume 8 (2003), pp. 46-57

[2] R. Katzman; C. Kawas The epidemiology of dementia and Alzheimer Disease (R.D. Terry; R. Katzman; K.L. Bick, eds.), Alzheimer Disease, Raven Press, New York, 1994, pp. 105-122

[3] N.T. Lautenschlager; L.A. Cupples; V.S. Rao; S.A. Auerbach; R. Becker; J. Burke; H. Chui; R. Duara; L. Volicer; S.C. Waring; J.H. Growdon; L.A. Farrer Risk of dementia among relatives of Alzheimer Disease patients in the MIRAGE study: what is in store for the oldest old?, Neurology, Volume 46 (1996), pp. 641-650

[4] J. Kang; H.G. Lemaire; A. Unterbeck; J.M. Salbaum; C.L. Masters; G. Multhap; K. Beyreuther; B. Muller-Hill The precursor of Alzheimer Disease amyloid A4 protein resembles a cell surface receptor, Nature, Volume 325 (1987), pp. 733-736

[5] D.J. Selkoe Normal and abnormal biology of B-Amyloid Precursor Protein, Annu. Rev. Neurosci., Volume 17 (1994), pp. 489-517

[6] R. Vassar; B.D. Bennett; S. Babu-Kahn; S. Kahn; E.A. Mendiaz; P. Denis; D.W. Teplow; S. Ross; P. Amarante; R. Loeloff; Y. Luo; S. Fisher; J. Fuller; J.C. Louis; F. Collins; J. Treanor; G. Rogers; M. Citron Beta-secretase cleavage of Alzheimer's Amyloid precursor protein by the transmembrane aspartic protease BACE, Science, Volume 286 (1999), pp. 735-741

[7] J.T. Jarrett; P.T. Lansbury Seeding one-dimensional crystallization of amyloid: a pathogenic mechanism in Alzheimer's Disease and scrapie?, Cell, Volume 73 (1993), pp. 1055-1058

[8] B.A. Yankner; L.K. Duffy; D.A. Kirschner Neurotrophic and neurotoxic effects of amyloid B protein: reversal by tachykinin neuropeptides, Science, Volume 250 (1990), pp. 279-282

[9] C.J. Pike; D. Burdick; A.J. Walencewicz; C.G. Glabe; C.W. Cotman Neurodegeneration induced by beta-amyloid peptides in vitro: the role of peptide assembly state, J. Neurosci., Volume 13 (1993), pp. 1676-1678

[10] A. Lorenzo; B.A. Yanker B-amyloid neurotoxicity requires fibril formation and is inhibited by Congo red, Proc. Natl Acad. Sci. USA, Volume 91 (1994), pp. 12243-12247

[11] K. Yasojima; H. Akiyama; E.G. McGeer; P.L. Geer Reduced neprilysin in high plaque areas of Alzheimer brain: a possible relationship to deficient degradation of beta-amyloid peptide, Neurosci. Lett., Volume 297 (2001), pp. 97-100

[12] W.Q. Qiu; D.M. Walsh; Z. Ye; K. Vekrellis; J. Zhang; M.B. Podlisny; M.R. Rosner; A. Safavi; L.B. Hersh; D.J. Lkoe Insulin-degrading enzyme regulates extracellular levels of amyloid beta-protein by degradation, J. Biol. Chem., Volume 273 (1998), pp. 32730-32738

[13] H. Zheng; M. Jiang; M.E. Trumbauer; R. Hopkins; D.J. Sirinathsinghji; K.A. Stevens; M.W. Corner; H.H. Slunt; S.S. Sisodia; H.Y. Chen; L.H. Van der Ploeg Mice deficient for the amyloid precursor protein gene, Ann. N.Y. Acad. Sci., Volume 777 (1996), pp. 421-426

[14] A. Kamal; A. Almenar-Queralt; J.F. LeBlanc; E.A. Roberts; L.S. Ldstein Kinesin-mediated axonal transport of a membrane compartment containing beta-secretase and presenilin-1 requires APP, Nature, Volume 414 (2001), pp. 643-648

[15] X. Cao; T.C. Sudhof A transcriptionally active complex of APP with Fe65 and histone acetyltransferase Tip60, Science, Volume 293 (2001), pp. 115-120

[16] M. Sastre; H. Steiner; K. Fuchs; A. Capell; G. Multhaup; M.M. Condron; D.B. Teplow; C. Haass Presenilin-dependent gamma-secretase processing of beta-amyloid precursor protein at a site corresponding to the S3 cleavage of Notch, EMBO Rep., Volume 2 (2001), pp. 835-841

[17] P. Cupers; I. Orlans; K. Craessaerts; W. Annaert; B. De Strooper The amyloid precursor protein (APP)-cytoplasmic fragment generated by gamma-secretase is rapidly degraded but distributes partially in a nuclear fraction of neurones in culture, J. Neurochem., Volume 78 (2001), pp. 1168-1178

[18] N. Arispe; H.B. Pollard; E. Rojas Giant multilevel cation channels formed by Alzheimer disease amyloid B protein in a bilayer membrane, Proc. Natl Acad. Sci. USA, Volume 90 (1993), pp. 10573-10577

[19] M.P. Mattson; B. Cheng; D. Davis; K. Bryant; I. Lieberburg; R.E. Rydel Beta-amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity, J. Neurosci., Volume 12 (1992), pp. 376-389

[20] M.P. Mattson; Y. Odman Different amyloidogenic peptides share a similar mechanism of neurotoxicity involving reactive oxygen species and calcium, Brain Res., Volume 676 (1995), pp. 219-224

[21] D.C. Lu; S. Rabizadeh; S. Chandra; R.F. Shayya; L.M. Ellerby; X. Ye; G.S. Salvesen; E.H. Koo; D.E. Bredesen A second cytotoxic proteolytic peptide derived from amyloid beta-protein precursor, Nat. Med., Volume 6 (2000), pp. 397-404

[22] M.A. Pericak-Vance; J.L. Bedout; P.C. Gaskell; A.D. Roses Linkage studies in familial Alzheimer Disease – evidence for chromosome 19 linkage, Am. J. Hum. Genet., Volume 48 (1991), pp. 1034-1050

[23] W.J. Strittmatter; A.M. Saunders; D. Schmechel; D. Goldgaber; A.D. Roses et al. Apolipoprotein E: high-affinity binding to B/A4 amyloid and increased frequency of type 4 allele in familial Alzheimer's Disease, Proc. Natl Acad. Sci. USA, Volume 90 (1993), pp. 1977-1981

[24] A. Saunders; W.J. Strittmatter; S. Schmechel; P. St George-Hyslop; M. Pericak-Vance; S.H. Joo; B.L. Rosi; J.F. Gusella; D. Crapper-McLachlan; J. Growden; M.J. Alberts; C. Hulette; B. Crain; D. Goldgaber; A.D. Roses Association of Apoliprotein E allele e4 with the late-onset familial and sporadic Alzheimer Disease, Neurology, Volume 43 (1993), pp. 1467-1472

[25] E.H. Corder; A.M. Saunders; N.J. Risch Apolipoprotein E type-2 allele decreases the risk of late-onset Alzheimer Disease, Nat. Genet., Volume 7 (1994), pp. 180-184

[26] E.H. Corder; A.M. Saunders; W.J. Srittmatter; D.E. Schmechel; P.C. Gaskell; G.W. Small; A.D. Roses; J.L. Haines; M.A. Pericak-Vance Gene dosage of Apolipoprotein E type 4 allele and the risk for Alzheimer's Disease in late onset families, Science, Volume 261 (1993), pp. 921-923

[27] G.W. Rebeck; T. Perls; H. West; P. Sodhi; L.A. Lipsitz; B.T. Man Reduced apolipoprotein e4 allele in the oldest old Alzheimer's patients and cognitively normal individuals, Neurology, Volume 175 (1994), pp. 46-48

[28] C.M. Van Duijn; P. de Knijff; M. Crutts; A. Wehnert; L.M. Havekes; A. Hofman; C. Van Broeckhoven Apolipoprotein E4 allele in a population-based study of early-onset Alzheimer Disease, Nat. Genet., Volume 7 (1994), pp. 74-78

[29] G. Maestre; R. Ottman; Y. Stern; R. Mayeux Apolipoprotein E and Alzheimer's Disease: ethnic variation in genotype risks, Ann. Neurol., Volume 37 (1995), pp. 254-259

[30] H.C. Hendrie; K.S. Hall; S. Hui Apolipoprotein E genotypes and Alzheimer's Disease in a community study of elderly African Americans, Ann. Neurol., Volume 37 (1995), pp. 118-121

[31] R. Mayeux; R. Ottman Synergistic effects of traumatic head injury and ApoE e4 in patients with Alzheimer's Disease, Neurology, Volume 45 (1995), pp. 555-557

[32] A.D. Roses; A.M. Saunders Head injury, amyloid B and Alzheimer's Disease, Nat. Med., Volume 1 (1995), pp. 603-604

[33] M.J. Alberts; C. Graffagnino ApoE genotype and survival from intracerebral hemorrhage, Lancet, Volume 346 (1995), p. 575

[34] M.F. Newman; N.D. Croughwell Predictors of cognitive decline after cardiac operation, Ann. Thorac. Surg., Volume 59 (1995), pp. 1326-1330

[35] J.M. Olichney; L.A. Hansen; D. Galasko; T. Saitoh; C.A. Hofstetter; R. Katzman; L.J. Thal The ApoE e4 allele is associated with increased neuritic plaques and cerebral amyloid angiopathy in AD and in Lewy Body Variant, Neurology, Volume 47 (1996), pp. 190-196

[36] P.H. St George-Hyslop; T. Tsuda; D.R. Crapper McLachlan; H. Karlinsky; D. Pollen; C. Lippa Alzheimer's Disease and possible gene interaction, Science, Volume 263 (1994), pp. 536-537

[37] D.E. Schmechel; A.M. Saunders; W.J. Strittmatter; S.H. Joo; C. Hulette; B. Crain; D. Goldgaber; A.D. Roses Increased vascular and plaque beta-A4 amyloid deposits in sporadic Alzheimer Disease patients with apolipoprotein e4, Proc. Natl Acad. Sci. USA, Volume 90 (1993), pp. 9649-9653

[38] W.J. Strittmatter; K.H. Weisgraber; D.Y. Huang; D. Schemechel; A.M. Saunders; A.D. Roses Binding of human lipoprotein E to synthetic amyloid beta peptide: isoform-specific effects and implications for late onset AD, Proc. Natl Acad. Sci. USA, Volume 90 (1993), pp. 8098-8102

[39] M.Z. Kounnas; R.D. Moir; G.W. Rebeck; A.I. Bush; W. Argaves; B.T. Hyman; D.K. Strickland LDL Receptor related protein, a multifunctional ApoE receptor binds secreted bAPP and mediates its degradation, Cell, Volume 82 (1995), pp. 331-340

[40] K.R. Bales; T. Verina; R.C. Dodel; Y. Du; L. Altsteil; M. Bender; P. Hyslop; E.M. Johnstone; S.P. Little; D.J. Cummins; P. Piccardo; B. Ghetti; S.M. Paul Lack of apolipoprotein E dramatically reduces amyloid beta-peptide deposition, Nat. Genet., Volume 17 (1997), pp. 254-256

[41] H. Runz; J. Rietdorf; I. Tomic; M. de Bernard; K. Beyreuther; R. Pepperkok; T. Hartmann Inhibition of intracellular cholesterol transport alters presenilin localization and amyloid precursor protein processing in neuronal cells, J. Neurosci., Volume 22 (2002), pp. 1679-1689

[42] K. Fassbender; M. Simons; C. Bergmann; M. Stroick; D. Lutjohann; P. Keller; H. Runz; S. Kuhl; T. Bertsch; K. von Bergmann; M. Hennerici; K. Beyreuther; T. Hartmann Simvastatin strongly reduces levels of Alzheimer's disease beta-amyloid peptides Abeta 42 and Abeta 40 in vitro and in vivo, Proc. Natl Acad. Sci. USA, Volume 98 (2001), pp. 5856-5861

[43] B. Wolozin; W. Kellman; P. Ruosseau; G.G. Celesia; G. Siegel Decreased prevalence of Alzheimer disease associated with 3-hydroxy-3-methyglutaryl coenzyme A reductase inhibitors, Arch. Neurol., Volume 57 (2000), pp. 1439-1443

[44] H. Jick; G.L. Zornberg; S.S. Jick; S. Seshadri; D.A. Drachman Statins and the risk of dementia, Lancet, Volume 356 (2000), pp. 1627-1631

[45] R.D. Terry; E. Masliah; L. Hansen Structural basis of the cognitive alterations in Alzheimer (R.D. Terry; E. Masliah; L. Hansen, eds.), Alzheimer Disease, Raven Press, New York, 1994, pp. 179-196

[46] R. Sherrington; E. Rogaev; Y. Liang; E. Rogaeva; G. Levesque; M. Ikeda; H. Chi; C. Lin; K. Holman; T. Tsuda; L. Mar; P. Fraser; J.M. Rommens; P. St George-Hyslop Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease, Nature, Volume 375 (1995), pp. 754-760

[47] D. Levitan; I. Greenwald Facilitation of lin-12-mediated signalling by sel-12, a Caenorhabditis elegans S182 Alzheimer's Disease gene, Nature, Volume 377 (1995), pp. 351-354

[48] G. Boulianne; I. Livne-Bar; J.M. Humphreys; E. Rogaev; P. St George-Hyslop Cloning and mapping of a close homologue of human presenilins in D. melanogaster, NeuroReport, Volume 8 (1997), pp. 1025-1029

[49] B. De Strooper; M. Beullens; B. Contreras; K. Craessaerts; D. Moechars; M. Bollen; P. Fraser; P. St George-Hyslop; F. Van Leuven Postranslational modification, subcellular localization and membrane orientation of the Alzheimer's Disease associated presenilins, J. Biol. Chem., Volume 272 (1997), pp. 3590-3598

[50] J. Walter; A. Capell; J. Grunberg; B. Pesold; A. Schindzielorz; R. Prior; M.B. Podlisny; P. Fraser; P. St George-Hyslop; D. Selkoe; C. Haass The Alzheimer's Disease associated presenilins are differentially phosphorylated proteins located predominantly within the endoplasmic reticulum, Mol. Med., Volume 2 (1996), pp. 673-691

[51] G. Thinakaran; D.R. Borchelt; M.K. Lee; H.H. Slunt; L. Spitzer; G. Kim; T. Ratovisky; F. Davenport; C. Nordstedt; M. Seeger; A.I. Levey; S.E. Gandy; N.A. Jenkins; N. Copeland; D.L. Price; S.S. Sisodia Endoproteolysis of presenilin 1 and accumulation of processed derivatives in vivo, Neuron, Volume 17 (1996), pp. 181-190

[52] M. Podlisny; M. Citron; P. Amarante; R. Sherrington; X. Weiming; J. Zhang; T. Diehl; G. Levesque; P. Fraser; C. Haass; E.H.M. Koo; P. Seubert; P. St George-Hyslop; D. Teplow; D.J. Selkoe Presenilin proteins undergo heterogeneous endoproteolysis between Thr291 and Ala299 and occur as stable N- and C-terminal fragments in normal brain tissue, Neurobiol. Dis., Volume 3 (1997), pp. 325-337

[53] G. Yu; M. Nishimura; S. Arawaka; D. Levitan; L. Zhang; A. Tandon; Y. Song; E. Rogaeva; F. Chen; T. Kawarai; A. Supala; L. Levesque; H. Yu; D.-S. Yang; E. Holmes; P. Milman; Y. Liang; D.-M. Zhang; D.H. Xu; C. Sato; E. Rogaev; M. Smith; C. Janus; Y. Zhang; R. Aebersold; L. Farrer; S. Sorbi; A.C. Bruni; P.E. Fraser; P.H. St George-Hyslop A novel protein (Nicastrin) modulates presenilin-mediated Notch/Glp1 And betaAPP processing, Nature, Volume 407 (2000), pp. 48-54

[54] Y. Gu; F. Chen; N. Sanjo; T. Kawarai; H. Hasegawa; M. Duthie; W. Li; X. Ruan; A. Luthra; H.T. Mount; A. Tandon; P.E. Fraser; P. George-Hyslop APH-1 interacts with mature and immature forms of presenilins and nicastrin and may play a role in maturation of presenilin–nicastrin complexes, J. Biol. Chem., Volume 278 (2003), pp. 7374-7380

[55] P.C. Wong; H. Zheng; H. Chen; M.E. Trumbauer; A.J. Roskams; H.Y. Chen; L.H. Van der Ploeg; D.L. Price; S.S. Sisodia Functions of the presenilins: generation and characterization of presenilin-1 null mice, Soc. Neurosci., Volume 22 (1996), p. 728

[56] B. De Strooper; W. Annert; P. Cupers; P. Saftig; K. Craessaerts; J.S. Mumm; E.H. Schroeter; V. Schrijvers; M.S. Wolfe; W.J. Ray; A. Goate; R. Kopan A presenilin-dependent gamma-secretase-like protease mediates release of Notch intracellular domain, Nature, Volume 398 (1999), pp. 518-522

[57] Y. Ye; N. Lukinova; M.E. Fortini Neurogenic phenotypes and altered Notch processing in Drosophila presenilin mutants, Nature, Volume 398 (1999), pp. 525-529

[58] M.S. Wolfe; W. Xia; B.L. Ostaszewski; T.S. Diehl; W.T. Kimberly; D.S. Selkoe Two transmembrane aspartates in presenilin 1 required for presenilin endoproteolysis and gamma-secretase activity, Nature, Volume 398 (1999), pp. 513-517

[59] M.S. Wolfe Presenilin and gamma-secretase: structure meets function, J. Neurochem., Volume 76 (2001), pp. 1615-1620

[60] F. Checler The multiple paradoxes of presenilins, J. Neurochem., Volume 76 (2001), pp. 1621-1627

[61] S. Sato; K. Kamino; T. Miki; A. Doi; K. Li; P. St George-Hyslop; T. Ogihara; Y. Sakaki Splicing mutation of presenilin-1 gene for early-onset familial Alzheimer's disease, Hum. Mutat. (Suppl.), Volume 1 (1998), p. S91-S94

[62] J. Perez-Tur; S. Froelich; G. Prihar; R. Crook; M. Baker; K. Duff; M. Wragg; J. Hardy; A. Goate; L. Lannfelt; M. Hutton A mutation in Alzheimer's disease destroying a splice acceptor site in the presenilin 1 gene, NeuroReport, Volume 7 (1996), pp. 297-301

[63] J.B. Kwok; K. Tadder; C. Fisher; M. Hallup; W. Brooks; G. Nicholson; P. St George-Hyslop; P.E. Fraser; N. Relkin; S.E. Gandy; R. Schofield; R. Martins Two novel PS1 mutations in early-onset Alzheimer Disease: evidence for association of PS1 mutations with a novel phenotype, NeuroReport, Volume 8 (1997), pp. 1537-1542

[64] R.N. Martins; B.A. Turner; R.T. Carroll; D. Sweeney; K.S. Kim; H.M. Wisniewski; J.P. Blass; G.E. Gibson; S.E. Gandy High levels of amyloid beta-protein from S182 (Glu246) familial Alzheimer's cells, NeuroReport, Volume 7 (1995), pp. 217-220

[65] D. Scheuner; L. Eckman; M. Jensen; X. Sung; M. Citron; N. Suzuki; T. Bird; J. Hardy; M. Hutton; L. Lannfelt; D. Selkoe; S. Younkin Secreted amyloid-b protein similar to that in the senile plaques of Alzheimer Disease is increased in vivo by presenilin 1 and 2 and APP mutations linked to FAD, Nat. Med., Volume 2 (1996), pp. 864-870

[66] K. Duff; C. Eckman; C. Zehr; X. Yu; C.H. Prada; J. Pereztur; M. Hutton; L. Refolo; B. Zenk; J. Hardy; S. Younkin Increased amyloid beta 42(43) in brains of mice expressing mutant presenilin 1, Nature, Volume 383 (1996), pp. 710-713

[67] M. Citron; D. Westaway; W. Xia; G. Carlson; T.S. Diehl; G. Levesque; K. Johnson-Wood; M. Lee; P. Seubert; A. Davis; D. Kholodenko; R. Motter; R. Sherrington; B. Perry; H. Yao; R. Strome; I. Lieberburg; J. Rommens; S. Kim; D. Schenk; P. Fraser; P. St George-Hyslop; D.J. Selkoe Mutant presenilins of Alzheimer's Disease increase production of 42 residue amyloid B-protein in both transfected cells and transgenic mice, Nat. Med., Volume 3 (1997), pp. 67-72

[68] E.I. Rogaev; R. Sherrington; E.A. Rogaeva; G. Levesque; M. Ikeda; Y. Liang; H. Chi; C. Lin; K. Holman; T. Tsuda; L. Mar; S. Sorbi; B. Nacmias; S. Piacentini; L. Amaducci; I. Chumakov; D. Cohen; L. Lannfelt; P.E. Fraser; J.M. Rommens; P. St George-Hyslop Familial Alzheimer's disease in kindreds with missense mutations in a novel gene on chromosome 1 related to the Alzheimer's Disease type 3 gene, Nature, Volume 376 (1995), pp. 775-778

[69] A. Herreman; D. Hartmann; W. Annaert; P. Saftig; K. Craessaerts; L. Serneels; L. Umans; V. Schrijvers; F. Checler; H. Vanderstichele; V. Backelandt; R. Dressel; P. Cupers; D. Huylebroeck; A. Zwijsen; F. Van Leuven; B. DeStrooper Presenilin 2 deficiecy causes a mild pulmonary phenotype and no changes in amyloid precursor protein processing but enhances the embryonic lethal phenotype of presenilin 1 deficiency, Proc. Natl Acad. Sci. USA, Volume 96 (1999), pp. 11872-11877

[70] R. Sherrington; S. Froelich; S. Sorbi; D. Campion; H. Chi; E.A. Rogaeva; G. Levesque; E.I. Rogaev; C. Lin; Y. Liang; M. Ikeda; L. Mar; A. Brice; Y. Agid; M.E. Percy; F. Clerget-Darpiux; H. Karlinsky; S. Piacentini; G. Marcon; B. Nacmias; L. Amaducci; T. Frebourg; L. Lannfelt; J.M. Rommens; P.H. St George-Hyslop Alzheimer's disease associated with mutations in presenilin-2 are rare and variably penetrant, Hum. Mol. Genet., Volume 5 (1996), pp. 985-988

[71] T.D. Bird; E. Levy-Lehad; J. Poorkaj; D. Nochlin; S.M. Sumi; E.J. Nemens; E. Wijsman; G.D. Schellenberg Wide range in age of onset for chromosome 1 related familial AD, Ann. Neurol., Volume 40 (1997), pp. 932-936

[72] T.D. Bird Familial Alzheimer's Disease in American descendents of the Volga Germans: probable genetic founder effect, Ann. Neurol., Volume 23 (1988), p. 25

[73] T.D. Bird; S.M. Sumi; E.J. Nemens; G.D. Schellenberg; G. Martin et al. Phenotypic heterogenity in familial Alzheimer's Disease: a study of 24 kindreds, Ann. Neurol., Volume 25 (1989), pp. 12-25

[74] M.A. Pericak-Vance; M.P. Bass; L.H. Yamaoka; P.C. Gaskell; W.K. Scott; H.A. Terwedow; M.M. Menold; P.M. Conneally; G.W. Small; J.M. Vance; A.M. Saunders; A.D. Roses; J.L. Haines Complete genomic screen in late-onset familial Alzheimer disease, Evidence for a new locus on chromosome 12, J. Am. Med. Assoc., Volume 278 (1997), pp. 1282-1283

[75] E. Rogaeva; S. Premkumar; Y. Song; S. Sorbi; N. Brindle; J. Paterson; R. Duara; G. Levesque; G. Yu; M. Nishimura; M. Ikeda; C. O'Toole; T. Kawarai; R. Jorge; J. Vilano; A. Bruni; L. Farrer; P. St George-Hyslop Evidence for an Alzheimer's Disease susceptibility locus on chr 12, and for further locus heterogeneity, J.A.M.A., Volume 280 (1998), pp. 614-618

[76] A. Myers; P. Holmans; H. Marshall; J. Kwon; D. Meyer; D. Ramic; S. Shears; J. Booth; F.W. DeVrieze; R. Crook; M. Hamshere; R. Abraham; N. Tunstall; F. Rice; S. Carty; S. Lillystone; P. Kehoe; V. Rudrasingham; L. Jones; S. Lovestone; J. Perez-Tur; J. Williams; M.J. Owen; J. Hardy; A.M. Goate Susceptibility locus for Alzheimer's disease on chromosome 10, Science, Volume 290 (2000), pp. 2304-2305

[77] N. Ertekin-Taner; N. Graff-Radford; L.H. Younkin; C. Eckman; M. Baker; J. Adamson; J. Ronald; J. Blangero; M. Hutton; S.G. Younkin Linkage of plasma Abeta42 to a quantitative locus on chromosome 10 in late-onset Alzheimer's disease pedigrees, Science, Volume 290 (2000), pp. 2303-2304

[78] L. Bertram; D. Blacker; K. Mullin; D. Keeney; J. Jones; S. Basu; S. Yhu; M.G. McInnis; R.C. Go; K. Vekrellis; D.J. Selkoe; A.J. Saunders; R.E. Tanzi Evidence for genetic linkage of Alzheimer's disease to chromosome 10q, Science, Volume 290 (2000), pp. 2302-2303

[79] J.M. Olson; K.A. Goddard; D.M. Dudek A second locus for very-late-onset Alzheimer disease: a genome scan reveals linkage to 20p and epistasis between 20p and the amyloid precursor protein region, Am. J. Hum. Genet., Volume 71 (2002), pp. 154-161

[80] W.K. Scott; E.R. Hauser; D.E. Schmechel; K.A. Welsh-Bohmer; G.W. Small; A.D. Roses; A.M. Saunders; J.R. Gilbert; J.M. Vance; J.L. Haines; M.A. Pericak-Vance Ordered-subsets linkage analysis detects novel Alzheimer disease loci on chromosomes 2q34 and 15q22, Am. J. Hum. Genet., Volume 73 (2003), pp. 1041-1051

[81] M.A. Pericak-Vance; J. Grubber; L.R. Bailey; D. Hedges; S. West; L. Santoro; B. Kemmerer; J.L. Hall; A.M. Saunders; A.D. Roses; G.W. Small; W.K. Scott; P.M. Conneally; J.M. Vance; J.L. Haines Identification of novel genes in late-onset Alzheimer's disease, Exp. Gerontol., Volume 35 (2000), pp. 1343-1352

[82] Y.J. Li; S.A. Oliveira; P. Xu; E.R. Martin; J.E. Stenger; C.R. Scherzer; M.A. Hauser; W.K. Scott; G.W. Small; M.A. Nance; R.L. Watts; J.P. Hubble; W.C. Koller; R. Pahwa; M.B. Stern; B.C. Hiner; J. Jankovic; C.G. Goetz; F. Mastaglia; L.T. Middleton; A.D. Roses; A.M. Saunders; D.E. Schmechel; S.R. Gullans; J.L. Haines; J.R. Gilbert; J.M. Vance; M.A. Pericak-Vance Glutathione S-transferase omega-1 modifies age-at-onset of Alzheimer disease and Parkinson disease, Hum. Mol. Genet., Volume 12 (2003), pp. 3259-3267

[83] T.T. Copley; S. Wiggins; S. Dufrasne; M. Bloch; S. Adam; W. McKellin; M.R. Hayden Are we all of one mind? Canadian Collaborative study for predictive testing for Huntington Disease, Am. J. Med. Genet., Volume 58 (1995), pp. 59-69

[84] E.A. Rogaeva; K.C. Fafel; Y.Q. Song; H. Medeiros; C. Sato; Y. Liang; E. Richard; E.I. Rogaev; P. Frommelt; A.D. Sadovnick; W. Meschino; K. Rockwood; M.A. Boss; R. Mayeux; P. St George-Hyslop Screening for PS1 mutations in a referral-based series of AD cases: 21 novel mutations, Neurology, Volume 57 (2001), pp. 621-625

[85] M. Tierney; J.P. Szalai; W.G. Snow; R.H. Fisher; A. Nores; G. Nadu; E. Dunn; P. St George-Hyslop A prospective study of the clinical utility of ApoE genotypes in the prediction of outcome in patients with memory impairment, Neurology, Volume 46 (1996), pp. 149-154

[86] N. Relkin; J. Breitner; L. Farrer; S. Gandy; J. Haines; A. Roses; M. Pericak-Vance et al. Apolipoprotein E genotyping in AD, Lancet, Volume 347 (1996), pp. 1091-1095

[87] R. Mayeux; M. Saunders; S. Shea; S. Mirra; D. Evans; A. Roses; B. Hyman; B. Crain; M.-X. Tang; C.H. Phelps Utility of the apolipoprotein E genotype in the diagnosis of Alzheimer's Disease, N.E.J.M., Volume 338 (1998), pp. 506-511

[88] M.B. Liddell; S. Lovestone; M.J. Owen Genetic risk of Alzheimer's disease: advising relatives, Br. J. Psychiatry, Volume 178 (2001), pp. 7-11

[89] M.R. Farlow Alzheimer's disease: clinical implications of the apolipoprotein E genotype, Neurology (Suppl.), Volume 48 (1997) no. 6, p. S30-S34

[90] J. Aerssens; P. Raeymaekers; S. Lilienfeld; H. Geerts; F. Konings; W. Parys APOE genotype: no influence on galantamine treatment efficacy nor on rate of decline in Alzheimer's disease, Dement. Geriatr. Cogn. Disord., Volume 12 (2001), pp. 69-77